UG

UNITED GUARDIAN INC - 10-Q Summary (Period Ended June 30, 2009)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2009, and the six-month period ended on the same date. United-Guardian, Inc. is a Delaware corporation engaged in the research, development, manufacturing, and marketing of cosmetic ingredients, personal care products, pharmaceuticals, and specialty industrial products. The company is classified as a smaller reporting company. As of August 1, 2009, there were 4,946,439 shares of common stock outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 14.8% ($886,049) for the six months ended June 30, 2009, compared to the prior year. This was driven primarily by a 90% increase in pharmaceutical sales due to a 5% price increase implemented in May 2009, which prompted customers to stock up. Conversely, personal care product sales decreased 4% for the six-month period.
• Profitability: Net income increased 21.3% to $1.91 million for the six-month period. The effective tax rate remained stable at approximately 33.0%.
• Cost Efficiency: Cost of sales as a percentage of sales decreased to 40.9% from 42.3% in the prior year, attributed to lower raw material costs.
• Liquidity: Working capital increased by $885,668 to $14.1 million. The current ratio improved significantly to 12:1 from 6.2:1, largely due to the payment of dividends payable ($1.38 million paid down from the prior year-end balance).
• Investment Income: Investment income decreased 25.6% for the six-month period due to lower interest rates and investment returns.

Guidance, Outlook, and Risks

• Outlook: Management anticipates that pharmaceutical product quantities sold in 2009 will be comparable to 2008 levels, noting that the recent sales spike was due to inventory stocking ahead of a price increase. The company expects working capital to be sufficient for the next twelve months and does not anticipate significant capital expenditures for the remainder of 2009.
• Pension Plan: The company is in the process of terminating its defined benefit pension plan, with regulatory approval expected in late 2009 or early 2010. No contributions were made to this plan in 2009.
• Risks: The filing includes standard forward-looking statement disclaimers regarding product development, market acceptance, competition, and economic conditions. No specific legal proceedings or defaults on senior securities were reported.
• Corporate Events: The filing notes the death of Dr. Alfred R. Globus, Chairman of the Board, in April 2009, which resulted in a change in control of the company. A new independent accountant was also appointed in July 2009.

Key Facts for Investor Verification

• Dividend Policy: The company paid $2.77 million in dividends during the six months ended June 30, 2009, representing a significant portion of its cash flow from operations.
• Customer Concentration: Approximately half of personal care products are sold outside the U.S., with International Specialty Products Inc. (ISP) being the largest marketing partner.
• Inventory Management: Inventory levels decreased by $167,898 during the period, contributing to positive cash flow from operations.
• Debt Status: The company has no outstanding long-term debt as of June 30, 2009, having paid off the remaining $6,657 in loans payable during the period.
• Accounting Changes: The company adopted several new accounting standards (SFAS 160, 141(R), 161, etc.) in 2009, though management stated these had no material impact on the financial statements.